These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16651413)

  • 1. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma.
    Zhang L; Huang J; Yang N; Liang S; Barchetti A; Giannakakis A; Cadungog MG; O'Brien-Jenkins A; Massobrio M; Roby KF; Katsaros D; Gimotty P; Butzow R; Weber BL; Coukos G
    Cancer Res; 2006 May; 66(9):4627-35. PubMed ID: 16651413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrative genomic analysis of phosphatidylinositol 3'-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer.
    Zhang L; Huang J; Yang N; Greshock J; Liang S; Hasegawa K; Giannakakis A; Poulos N; O'Brien-Jenkins A; Katsaros D; Butzow R; Weber BL; Coukos G
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5314-21. PubMed ID: 17875760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer.
    Regala RP; Weems C; Jamieson L; Khoor A; Edell ES; Lohse CM; Fields AP
    Cancer Res; 2005 Oct; 65(19):8905-11. PubMed ID: 16204062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis.
    Weichert W; Gekeler V; Denkert C; Dietel M; Hauptmann S
    Int J Oncol; 2003 Sep; 23(3):633-9. PubMed ID: 12888898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling.
    Baldwin RM; Garratt-Lalonde M; Parolin DA; Krzyzanowski PM; Andrade MA; Lorimer IA
    Oncogene; 2006 May; 25(20):2909-19. PubMed ID: 16331246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker.
    Huddleston HG; Wong KK; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2005 Jan; 96(1):77-83. PubMed ID: 15589584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
    Pavan S; Olivero M; Corà D; Di Renzo MF
    Eur J Cancer; 2013 Mar; 49(4):964-73. PubMed ID: 23079474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical protein kinase Cι (PKCι) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to Anoikis via PKCι-SKP2-AKT pathway.
    Liu SG; Wang BS; Jiang YY; Zhang TT; Shi ZZ; Yang Y; Yang YL; Wang XC; Lin DC; Zhang Y; Yang H; Cai Y; Zhan QM; Wang MR
    Mol Cancer Res; 2011 Apr; 9(4):390-402. PubMed ID: 21310827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16 overexpression: a potential early indicator of transformation in ovarian carcinoma.
    Shigemasa K; Hu C; West CM; Clarke J; Parham GP; Parmley TH; Korourian S; Baker VV; O'Brien TJ
    J Soc Gynecol Investig; 1997; 4(2):95-102. PubMed ID: 9101469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer.
    Macleod K; Mullen P; Sewell J; Rabiasz G; Lawrie S; Miller E; Smyth JF; Langdon SP
    Cancer Res; 2005 Aug; 65(15):6789-800. PubMed ID: 16061661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer.
    Hengstler JG; Lange J; Kett A; Dornhöfer N; Meinert R; Arand M; Knapstein PG; Becker R; Oesch F; Tanner B
    Cancer Res; 1999 Jul; 59(13):3206-14. PubMed ID: 10397267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells.
    Chan DW; Liu VW; Tsao GS; Yao KM; Furukawa T; Chan KK; Ngan HY
    Carcinogenesis; 2008 Sep; 29(9):1742-50. PubMed ID: 18632752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.
    Nanjundan M; Nakayama Y; Cheng KW; Lahad J; Liu J; Lu K; Kuo WL; Smith-McCune K; Fishman D; Gray JW; Mills GB
    Cancer Res; 2007 Apr; 67(7):3074-84. PubMed ID: 17409414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caspase-1alpha is down-regulated in human ovarian cancer cells and the overexpression of caspase-1alpha induces apoptosis.
    Feng Q; Li P; Salamanca C; Huntsman D; Leung PC; Auersperg N
    Cancer Res; 2005 Oct; 65(19):8591-6. PubMed ID: 16204022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
    Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Kinase-zeta inhibits collagen I-dependent and anchorage-independent growth and enhances apoptosis of human Caco-2 cells.
    Mustafi R; Cerda S; Chumsangsri A; Fichera A; Bissonnette M
    Mol Cancer Res; 2006 Sep; 4(9):683-94. PubMed ID: 16940160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
    Li H; Weinstein IB
    Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer.
    Fields AP; Frederick LA; Regala RP
    Biochem Soc Trans; 2007 Nov; 35(Pt 5):996-1000. PubMed ID: 17956262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.